Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garth Powis

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2012
The promise of patient-derived xenografts: the best laid plans of mice and menScott Kopetz, Robert Lemos, Garth Powis
Molecular Cancer Research : MCR|July 16, 2003
Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosisLarisa Nonn, Margareta Berggren, Garth Powis
Seminars in Oncology|August 8, 2006
The hypoxic inducible stress response as a target for cancer drug discoverySarah J Welsh, Mei Yee Koh, Garth Powis
Molecular and Cellular Biology|October 8, 2008
Hypoxia-associated factor, a novel E3-ubiquitin ligase, binds and ubiquitinates hypoxia-inducible factor 1alpha, leading to its oxygen-independent degradationMei Yee Koh, Bryant G Darnay, Garth Powis
The Journal of Organic Chemistry|October 25, 2001
Novel Water-Soluble Diorganyl Tellurides with Thiol Peroxidase and Antioxidant ActivityTakahiro Kanda, Lars Engman, Ian A. Cotgreave, et al.
Trends in Biochemical Sciences|September 24, 2008
HIF-1 regulation: not so easy come, easy goMei Yee Koh, Taly R Spivak-Kroizman, Garth Powis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2009
Inhibiting the hypoxia response for cancer therapy: the new kid on the blockMei Yee Koh, Taly R Spivak-Kroizman, Garth Powis
Cancer Research|April 23, 2011
The hypoxia-associated factor switches cells from HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasionMei Yee Koh, Robert Lemos, Xiuping Liu, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|December 25, 2009
HIF-1alpha and cancer therapyMei Yee Koh, Taly R Spivak-Kroizman, Garth Powis
Molecular and Cellular Biology|January 17, 2003
The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous miceLarisa Nonn, Ryan R Williams, Robert P Erickson, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2012
The promise of patient-derived xenografts: the best laid plans of mice and menScott Kopetz, Robert Lemos, Garth Powis
Molecular Cancer Research : MCR|July 16, 2003
Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosisLarisa Nonn, Margareta Berggren, Garth Powis
Seminars in Oncology|August 8, 2006
The hypoxic inducible stress response as a target for cancer drug discoverySarah J Welsh, Mei Yee Koh, Garth Powis
Molecular and Cellular Biology|October 8, 2008
Hypoxia-associated factor, a novel E3-ubiquitin ligase, binds and ubiquitinates hypoxia-inducible factor 1alpha, leading to its oxygen-independent degradationMei Yee Koh, Bryant G Darnay, Garth Powis
The Journal of Organic Chemistry|October 25, 2001
Novel Water-Soluble Diorganyl Tellurides with Thiol Peroxidase and Antioxidant ActivityTakahiro Kanda, Lars Engman, Ian A. Cotgreave, et al.
Trends in Biochemical Sciences|September 24, 2008
HIF-1 regulation: not so easy come, easy goMei Yee Koh, Taly R Spivak-Kroizman, Garth Powis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2009
Inhibiting the hypoxia response for cancer therapy: the new kid on the blockMei Yee Koh, Taly R Spivak-Kroizman, Garth Powis
Cancer Research|April 23, 2011
The hypoxia-associated factor switches cells from HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasionMei Yee Koh, Robert Lemos, Xiuping Liu, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|December 25, 2009
HIF-1alpha and cancer therapyMei Yee Koh, Taly R Spivak-Kroizman, Garth Powis
Molecular and Cellular Biology|January 17, 2003
The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous miceLarisa Nonn, Ryan R Williams, Robert P Erickson, et al.
Pageof 10